Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on photocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117126077B reveals a green visible-light iron catalyzed route for 4-arylbutyronitrile. Achieve 100% atom economy and cost reduction in fine chemical manufacturing.
Patent CN106467481B enables visible-light synthesis of indole ketones without transition metals, offering cost reduction and high purity for pharmaceutical manufacturing supply chains.
Patent CN112409275B reveals a green photocatalytic route for 3-acylquinoxalinones using visible light and eosin Y, offering cost-effective pharma intermediate manufacturing.
Patent CN112142680B details a metal-free photocatalytic route for 3-trifluoroalkylquinoxalinones, offering cost-effective and scalable manufacturing for pharmaceutical intermediates.
Patent CN111925308B reveals a mild iridium-catalyzed photocatalytic route for N-substituted sulfone diimines, offering reliable pharmaceutical intermediate supply chains.
This patent reveals a novel visible-light-driven iron-catalyzed method for aryl benzyl sulfide synthesis, offering enhanced substrate scope and milder conditions for reliable pharmaceutical intermediate production.
Novel visible-light photocatalytic method for sulfuryl gamma-lactone synthesis enabling high-purity pharmaceutical intermediates with improved supply chain reliability and cost efficiency.
Patent CN109053625B enables mild visible-light synthesis of benzothiazole derivatives eliminating transition metals to reduce costs and enhance supply chain reliability for pharmaceutical intermediates.
Patent CN104844651A enables green synthesis of fluorinated phenanthridine derivatives with mild conditions, reducing waste and enhancing supply chain reliability for fine chemical manufacturing.
Novel visible light-mediated synthesis achieves high-purity API intermediates with mild conditions and scalable production for reliable supply chain.
Patent CN110590788B enables high-purity 2-acyl-pyrroloindole API intermediates through visible-light catalysis, reducing manufacturing costs and lead times.
Novel visible-light catalyzed synthesis of 3-aryl-2H-indazoles enables high-purity pharmaceutical intermediates with reduced manufacturing costs and faster scale-up.
Reduce production costs and metal residues with this efficient photocatalytic route for high-purity o-amino aromatic ketones in drug development.
Discover how visible light photocatalysis enables 90% yield in fluoroalkyl heterocycle synthesis, eliminating high-pressure equipment and reducing supply chain risks for pharmaceutical intermediates.
Discover how visible light photocatalysis enables safer, higher-yield synthesis of 3-acyl spirotrienones for pharmaceutical intermediates. Reduce supply chain risks.
Discover a 75-96% yield, room-temperature synthesis of 1,3,4-oxadiazole derivatives. Eliminate metal residues and toxic reagents for safer, cost-effective API manufacturing.
Eliminate toxic reagents and noble metals in tetracyclic quinazolinone production with 83% yield. Scale to 100MT/yr with NINGBO INNO PHARMCHEM's CDMO expertise.
Solve metal residue issues in 3-thioindole production with metal-free photocatalysis. Achieve 70% yield, simplified process, and GMP compliance for your drug development projects.
Solve high-cost catalyst issues in indoloisoquinolinone synthesis. This metal-free, visible-light method offers 60-72% yield with easy scale-up for drug development.
Discover how photocatalytic N-alpha arylation eliminates HAT reagents, reduces costs, and achieves 99% purity for pharmaceutical intermediates. Scale to 100 MT/annual with CDMO expertise.